Managing the Integration of Technologies: Development of the Immunoassay
Published online by Cambridge University Press: 10 March 2009
Abstract
Many factors, including cultural, economic, technical, and regulatory influences, affect how different technologies come together for today's medical diagnostic products. An analysis of the development of automated immunoassay systems reveals that companies used a variety of approaches to access needed technologies, that mature technologies play an important role in the development of new products, and that implementation seemed more important in these companies than strategy.
- Type
- Special Section: Industry and the Generation of Technology
- Information
- International Journal of Technology Assessment in Health Care , Volume 9 , Issue 2 , Spring 1993 , pp. 162 - 166
- Copyright
- Copyright © Cambridge University Press 1993
References
REFERENCES
1.Bernson, S. A., & Yalow, R. S.Recent studies on insulin-binding antibodies. Annals of the New York Academy of Sciences, 1959, 82, 338–44.CrossRefGoogle Scholar
2.Koehler, G., & Milstein, C.Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 1975, 495–97.CrossRefGoogle Scholar
3.Roberts, E. B. Managing technological innovation in the medical device industry. Research Technology Management, 1989, 07-08, 34–41.CrossRefGoogle Scholar
4.Rubenstein, K. E., Schneider, R. S., & Ullman, E. F. “Homogeneous” enzyme immunoassay. A new immunochemical technique. Biochemical and Biophysical Research Communications, 1972, 846–51.CrossRefGoogle Scholar
- 1
- Cited by